Ecuadorian researcher develops new targeted therapy for aggressive brain cancer

Mayo Clinic researcher María José Ulloa wins grant to test new glioblastoma treatment using repurposed drugs and immune reprogramming.

Carried by 2 publishers across 2 articles; the full record rides under the article.

TruthFoundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.